Login to Your Account


Depressed patients are less responsive to chemotherapy

By John Fox
Staff Writer

Friday, December 30, 2016

HONG KONG – A neurotrophic brain protein has been shown to play an important role in how well cancer patients respond to chemotherapy, according to the findings of a new Chinese study reported Dec. 17, 2016, during the European Society for Medical Oncology (ESMO) Asia 2016 Congress in Singapore.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription